Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.
Christian VitugKatherine LajkoszJulian ChavarriagaAndres LlanoShayan DinEunice VillegasCynthia KukAmy ChanBruce GaoOtto HemminkiDhiral KotJimmy MisurkaTheodorus H van der KwastChristopher WallisMichael A S JewettMark S SolowayNeil E FleshnerGirish S KulkarniAlexandre R ZlottaPublished in: BJU international (2023)
This study supports that properly selected patients with recurrent, apparent TaLG NMIBC can be safely managed with OF under local anaesthesia with occasional TURBT for larger or numerous recurrent tumours, without compromising long-term oncological outcomes. This approach could generate substantial cost-saving to healthcare systems, is patient-friendly, and could be adopted more widely.